£300K
The bridging round extends the company runway ahead of a larger raise planned for 2025.
SleepCogni
SleepCogni builds digital technology to transform insomnia care and sleep health.
£2.4MTotal raised
SleepCogni is a medical technology company based in Sheffield that develops digital solutions for insomnia care. The firm combines clinical insights with advanced monitoring to improve patient outcomes.
Filed accounts
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Current assets
Members only
Employees
Members only
Cash, assets and headcount from SleepCogni's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
RM
Rich Mills
CEO
Rich currently serves as chief executive officer at SleepCogni and previously founded ProMOTION and The Walnut Club. His earlier career includes roles in sales and account management at Sprint International, Global One, and General Telecom.
LinkedInRM
Richard Mills
CEO
Richard brings founding and executive experience, currently serving as chief executive officer at SleepCogni after previously founding ProMOTION and The Walnut Club.
Colin Greene
Executive
Colin serves as an executive and chair at SleepCogni, alongside non-executive director roles at ScrubMarine, Transreport, and other firms. He also operates as a partner at PXN Group.
LinkedIn
Andrew Morfey
Executive
Andrew brings commercial leadership and governance experience from roles at Equipsme, Stag Solutions, and AXA Health. He previously served as finance director at Health-on-Line.
LinkedInRd
Richard di Benedetto
Chairman
Mark Milton-Edwards
Non-Executive Director
Mark brings digital health and pharmaceutical industry experience from his roles at Teva Pharmaceuticals, SleepCogni, and Digital Medical Innovations.
LinkedIn
Investors
- £1.4MInnovate UKFollow-on
- £234K
- £463KInnovate UKLead
Funding history
£1.4M
The round was backed by Chasnay Capital Partners alongside existing investors, retail investors, and Innovate UK.
£234K
The MedTech start-up received its second award from the UK innovation agency via the Biomedical Catalyst scheme.
£463K
Innovate UK has backed the medical device firm to advance clinical trials and research.